MEGIN Spotlights

MEGIN

Based in Helsinki, Finland, MEGIN is a global leader in functional neuroimaging, developing innovative solutions for Neurology, Neurosurgery & Research. We are reshaping the field of functional brain imaging, with the aim of ensuring that every scientific advancement translates into meaningful health outcomes for patients worldwide.

  1. Sep 22

    Exploring Early Brain Development Through Music, Speech and MEG | Dr. Christina Zhao

    In this MEGIN Spotlight, we welcome Dr. Christina Zhao, Director of the Lab for Early Auditory Perception (LEAP) within the Institute for Learning and Brain Sciences (I-LABS), Washington. Dr. Zhao discusses her research into early learning and brain development, with a focus on how infants' brains process speech and music and how musical experiences can shape early development. She also shares insights into the use of infant MEG within I-LABS, translating neuroscience research into educational practice, and the future directions of research supported by her new professorship.   In this episode: Introduction to Dr. Christina Zhao and ILABS The mission and focus of ILABS and LEAP Dr. Zhao's journey into auditory neuroscience Using MEG to study infant brain responses Music's role in shaping infant speech and language Translating research into educational and community impact The significance of the Paros Endowed Professorship and future research   To learn more: Read the paper "Infant brain imaging using magnetoencephalography: Challenges, solutions, and best practices:" Human Brain Mapping | Neuroimaging Journal | Wiley Online Library. Watch the accompanying video featuring how to test infants in the MEG: Infant brain imaging using magnetoencephalography: Challenges, solutions, and best practices Institute for Learning and Brain Sciences (I-LABS): https://ilabs.uw.edu The Lab for Early Auditory Perception (LEAP): https://sites.uw.edu/babyleap/   Don't forget to like and subscribe for more conversations at the forefront of brain science. MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice. Consult your caregiver for medical advice.  TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

  2. Apr 30

    Unlocking the future of brain health | Inside MYndspan's MEG scans

    In this episode of the MEGIN Spotlights, we explore the rapidly evolving world of consumer brain health with MYndspan - a pioneering company making advanced brain insights more accessible than ever. Joined by co-founder & CEO Caitlin Baltzer and Chief Scientific Officer Dr. Benjamin Dunkley, we dive into how MEG (magnetoencephalography) technology is moving beyond hospitals and research labs into consumer health insights. 🔍In this episode, we cover: Why consumer health data is reshaping the future of healthcare How MYndspan uses non-invasive brain scans to deliver actionable insights The concept of "brain age" and what it reveals about your cognitive health Real-world case studies - from athletes to high-performance individuals The power of combining brain data with lifestyle factors like sleep, nutrition, and stress How MEG is unlocking earlier detection of functional brain changes, before symptoms appear 💡 With demand for proactive, personalized health insights on the rise, MYndspan is helping bridge the gap between neuroscience innovation and everyday wellbeing, powered by MEGIN's world-leading MEG technology. 👉 Don't forget to like, subscribe, and follow MEGIN for more conversations at the forefront of brain science. MYndspan website: https://myndspan.com MYndspan publications: https://myndspan.com/publications/ MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice. Consult your caregiver for medical advice. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Please contact MEGIN for further information. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

About

Based in Helsinki, Finland, MEGIN is a global leader in functional neuroimaging, developing innovative solutions for Neurology, Neurosurgery & Research. We are reshaping the field of functional brain imaging, with the aim of ensuring that every scientific advancement translates into meaningful health outcomes for patients worldwide.